Cybin Inc. - stock earnings
CYBN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -22.9 million USD | ? USD |
| 2023Q3 | -8.7 million USD | ? USD |
| 2023Q2 | -9.3 million USD | ? USD |
| 2023Q1 | -10.1 million USD | ? USD |
| 2022Q4 | -7.9 million USD | ? USD |
| 2022Q3 | -7.3 million USD | ? USD |
| 2022Q2 | -10.1 million USD | ? USD |
| 2022Q1 | -14.5 million USD | ? USD |
| 2021Q4 | -13.6 million USD | ? USD |
| 2021Q3 | -13.9 million USD | ? USD |
| 2021Q2 | -11.9 million USD | ? USD |
| 2021Q1 | -11.0 million USD | -109 USD |
| 2020Q4 | -9.0 million USD | ? USD |
| 2020Q3 | -36740 USD | ? USD |
| 2020Q2 | -3.2 million USD | 636505 USD |
CYBN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.6 million USD | ? USD |
| 2022 | -57.1 million USD | ? USD |
| 2021 | -25.7 million USD | 687895 USD |
| 2020 | -1371 USD | ? USD |
| 2019 | -74854 USD | ? USD |
CYBN
Price: $0.35
52 week price:
Earnings Per Share: -0.22 USD
P/E Ratio: -1.83
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 1.6 million
Market Capitalization: 288.6 million